Abiopharma

🔍 SLESSOR MIKE (Director)

Company: FORMFACTOR INC (FORM)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 5,908 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 459,763.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,288 shares of Common Stock at $144.68 per share (Direct)
  Date: 2026-05-07 | Code: F | equity_swap_involved: 0 | shares_owned_after: 456,475.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 5,908 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,908.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: These shares of common stock reflect the settlement of restricted stock units of the Issuer. Each Restricted Stock Unit (RSU) is convertible into a share of common stock on a 1-for-1 basis.
• F2: Represents the number of shares withheld upon vesting of restricted stock units to cover tax withholding obligations.
• F3: The Restricted Stock Units granted on August 7, 2023 vest in twelve (12) quarterly installments beginning on November 7, 2023 and ending on August 7, 2026 and will be settled into shares of common stock on or following the vesting dates.
• F4: If the reporting person's employment is terminated for any reason before an applicable Vesting Date, all restricted stock units that have not yet vested shall be forfeited without consideration, except as provided in the change of control severance agreement and any other agreements regarding equity vesting and exercisability between the reporting person and Issuer, which agreements or form agreements are filed with the SEC.